CLINICAL_TRIALS
trial_result
· 2025-12-29
Clinical Trial Update: Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast [Phase 2]
Summary
A Phase 2 clinical trial update reports wide excision alone as a treatment option for ductal carcinoma in situ of the breast; the study is currently active but …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Ductal Carcinoma in Situ of the Breast | Phase 2 | Status: ACTIVE_NOT_RECRUITING